Small private practices and health-care providers are facing mounting financial pressures as crucial reimbursement systems remain down for the ninth day, following the cyberattack on Change Healthcare.
Change Healthcare offers tools for payment and revenue cycle management that help facilitate transactions between providers and most major insurance companies. Its parent company UnitedHealth Group discovered that a cyber threat actor breached part of the unit’s information technology network on Feb. 21, according to a filing with the U.S. Securities and Exchange Commission.
As a result, the company isolated and disconnected the impacted systems “immediately upon detection” of the threat, the filing said.
The fallout has caused a ripple of disruption across the U.S. health-care system.
Doctors told CNBC the outage has left them unable to check patients’ eligibility for treatment or fill prescriptions electronically, which has created more administrative responsibility for workers that are already overwhelmed by clerical work. Perhaps more importantly, providers have been unable to receive reimbursements from insurers, effectively grinding many health systems’ revenue cycles to a halt.
Smaller and mid-sized practices that rely on reimbursement cash flow to operate are making tough decisions about how to stay afloat. If the outage drags on for too long, experts say some practices may have to close their doors for good.
Dr. Purvi Parikh, an allergist and immunologist with a private practice in New York City, told CNBC that the breach has been a “mess” and a “big stressor.” Like many others, she said her practice hasn’t been able to receive reimbursements from insurers for patient visits, which makes it difficult for the practice to pay for operational expenses like payroll and medical supplies.
Switching to a new platform could take weeks, Parikh said, so there’s no immediate workaround available. As of Thursday, Change Healthcare has not shared any updates about when it expects its systems to be back online.
“The most frustrating part is that nobody has any answers or solutions,” Parikh said. “We’re kind of just stuck.”
Change Healthcare on Thursday said that ransomware group Blackcat is behind the attack. Blackcat, also called Noberus and ALPHV, steals sensitive data from institutions and threatens to publish it unless a ransom is paid, according to a December release from the U.S. Department of Justice.
The company said it is working with law enforcement and third party consultants like Mandiant, which is owned by Google, and cybersecurity software vendor Palo Alto Networks to assess the breach.
“Patient care is our top priority and we have multiple workarounds to ensure people have access to the medications and the care they need,” Change Healthcare said in a statement to CNBC.
Dr. Kiranjit Khalsa, an allergist and immunologist who runs an independent practice in Scottsdale, Arizona, said her staff has been working longer hours to try and accommodate the extra work as a result of the breach, as well as manually calling in prescriptions.
She said the problems around reimbursement have been the “biggest burden,” since she is worried about how she can continue to support her patients and employees. Khalsa is considering cutting back hours for staff and even closing the clinic for a few days.
“I worry about providing for them,” Khalsa told CNBC in an interview. “I also worry about: Where am I going to get this money if it does not come through? Do I need to take a loan out to keep the clinic afloat?”
Even when Change Healthcare’s systems do come back online, there are a lot of unanswered questions about what will happen next, according to Dr. Dan Inder Sraow, an interventional cardiologist who owns a private practice around Phoenix, Arizona. He said it’s not clear whether Change Healthcare will take on the responsibility of processing all the claims or if he’ll need to hire additional staff to help.
“I don’t think that people are aware that the actual people providing the services are not able to extract revenue for those services,” Dr. Sraow told CNBC. “We don’t know how long that’s going to be, and that’s such a dangerous, dangerous thing.”
Dr. Jesse Ehrenfeld, president of the American Medical Association, said he has spent days fielding calls from concerned colleagues.
He said he spoke with one doctor who runs an oncology practice and only has up to two weeks’ worth of cash on hand. If the outage drags out, the practice won’t be able to buy the chemotherapy that its patients depend on for treatment.
Since many providers are operating on razor-thin margins, Ehrenfeld said there is a possibility that some will go out of business.
“We have so many practices that are on the fringe, particularly smaller practices, where they are just scraping by,” Ehrenfeld told CNBC in an interview. “Any aberration in the system where, ‘Oh, you don’t get checks for two weeks,’ obviously is a situation that does put practices at risk.”
In 2022, Change Healthcare merged with the provider Optum, which services more than 100 million patients in the U.S. and is owned by UnitedHealth, the country’s biggest health-care company by market cap.
The American Medical Association vocally opposed the merger, writing in a letter to the DOJ that the union could stifle competition, give UnitedHealth access to large data stores and potentially disrupt patient care.
The merger ultimately went through, but the DOJ has recently launched an antitrust investigation into UnitedHealth, according to a Wall Street Journal report Tuesday.
“It’s just sort of like a perfect storm of regulatory issues [and] lack of competition — and unfortunately, the people who are really going to suffer are patients and individuals who work in the healthcare system,” said Dr. Ravi Parikh, a retina specialist that owns and operates a practice in New York City.
The cyberattack has left Parikh’s clinic without a way to receive reimbursements for the expensive medications it administers. He said he has been thinking about contingency plans, such as seeking out cheaper medications and asking some patients to pay upfront, but his focus is on providing the best care possible.
“The health care system could eventually come to a halt because a lot of clinics and pharmacies might not be viable,” Parikh said.
Alexander Karp, chief executive officer and co-founder of Palantir Technologies Inc.
Scott Eelis | Bloomberg | Getty Images
Palantir‘s astronomical rise since its public debut on the New York Stock Exchange in a 2020 direct listing has been nothing short of a whirlwind.
Over nearly five years, the Denver-based company, whose cofounders include renowned venture capitalist Peter Thiel and current CEO Alex Karp, has surged more than 1,700%. At the same time, its valuation has broken new highs, dwarfing some of the world’s technology behemoths with far greater revenues.
The artificial intelligence-powered software company continued its ascent last week after posting its first quarter with more than $1 billion in revenue, reaching new highs and soaring past a $430 billion market valuation.
Shares haven’t been below $100 since April 2025. The stock last traded below $10 in May 2023, before beginning a steady climb higher.
Last month, retail poured $1.2 billion into Palantir stock, according to data from Goldman Sachs.
Here’s a closer look at Palantir’s growth over the last five years and how the company compares to megacap peers.
Government money
Government contracts have been one of Palantir’s biggest growth areas since its inception.
Last quarter, the company’s U.S. government revenue grew 53% to $426 million. Government accounted for 55% of the company’s total revenue but commercial is showing promise. Those revenues in the U.S. grew 93% last quarter, Palantir said.
Still, one of the company’s oldest customers is the U.S. Army.
Earlier this month, the company inked a contract worth up to $10 billion for data and software to streamline efficiencies and meet growing military needs. In May, the Department of Defense boosted its agreement with Palantir for AI-powered battlefield capabilities by $795 million.
“We still believe America is the leader of the free world, that the West is superior,” Karp said on an earnings call earlier this month. “We have to fight for these values; we should give American corporations, and, most importantly, our government, an unfair advantage.”
Beyond the U.S.
The U.S. has been a key driver of Palantir’s growth, especially as the company scoops up more contracts with the U.S. military.
Palantir said the U.S. currently accounts for about three-quarters of total revenues. Commercial international revenues declined 3% last quarter and analysts have raised concerns about that segment’s growth trajectory.
Over the last five years, U.S. revenues have nearly quintupled from $156 million to about $733 million. Revenues outside the U.S. have doubled from about $133 million to $271 million.
Paying a premium
Palantir’s market capitalization has rapidly ascended over the last year as investors bet on its AI tools, while its stock has soared nearly 500%.
The meteoric rise placed Palantir among the top 10 U.S. tech firms and top 20 most valuable U.S. companies. But Palantir makes a fraction of the revenue of the companies in those lists.
Last quarter, Palantir reported more than $1 billion in quarterly revenue for the first time, and its forward price-to-earnings ratio has surged past 280 times.
By comparison, Apple and Microsoft posted revenue of $94 billion and $76 billion during the period, respectively, and carry a PE ratio of nearly 30 times.
Forward PE is a valuation metric that compares a company’s future earnings to its current share price. The higher the PE, the higher the growth expectations or the more overvalued the asset. A lower price-to-earnings ratio suggests slower growth or an undervalued asset.
Most of the Magnificent Seven stocks, except for Nvidia and Tesla, have a forward PE that hovers around the 20s and 30s. Nvidia trades at more than 40 times forward earnings, while Tesla’s sits at about 198 times.
At these levels, investors are paying a jacked-up premium to own shares of one of the hottest AI stocks on Wall Street as its valuation has skyrocketed to astronomical heights.
“This is a once-in-a-generation, truly anomalous quarter, and we’re very proud,” Karp said on an earnings call following Palantir’s second-quarter results. “We’re sorry that our haters are disappointed, but there are many more quarters to be disappointed.”
Tim Cook, chief executive officer of Apple Inc., during the Apple Worldwide Developers Conference (WWDC) at Apple Park campus in Cupertino, California, US, on Monday, June 9, 2025.
Apple said the redesigned feature is coming to some Apple Watch Series 9, Series 10, and Apple Watch Ultra 2 users on Thursday. The update was possible because of a recent U.S. Customs ruling, the company said.
In 2023, the International Trade Commission found that Apple’s blood oxygen sensors infringed on intellectual property from Masimo, a medical technology company. Apple paused the sale of some of its watches and began selling modified versions of the wearables without the blood oxygen feature.
“Apple’s teams work tirelessly to create products and services that empower users with industry-leading health, wellness, and safety features that are grounded in science and have privacy at the core,” the company said in a release announcing the feature rollout.
Bitcoin hit a new record late Wednesday as ether climbed even closer to its all-time high.
The flagship cryptocurrency rose as high as $124,496, surpassing its July record of 123,193.63, according to Coin Metrics. Ether rose to $4,791.19 overnight, edging closer to its 2021 record of $4,866.01.
Both coins took a hit Thursday, however, after July’s wholesale inflation data came in much hotter than expected. Bitcoin was lower by 3% at $118,481.00 while ether fell 2% to $4,629.20.
Stock Chart IconStock chart icon
Bitcoin hit a new record overnight, surpassing its July all-time high
The initial gains were sparked by Tuesday’s cooler-than-expected July inflation report, which had lifted investor optimism for rate cuts from the Federal Reserve at the end of its September policy meeting. The coins rallied with the stock market for two days. On Wednesday, the S&P 500 and Nasdaq also scaled new records.
For the week, bitcoin is on pace for a nearly 2% gain, while ether has rallied more than 14%. Ether flipped bitcoin as the crypto market leader in June, gaining 85% since then thanks to heavy institutional buying, tightening supply and adoption from corporate accumulators – all under the backdrop of a friendlier regulatory environment for the crypto industry. Jake Kennis, analyst at Nansen, said the rally likely has more room to run given the flows remain strong.
“Bitcoin hitting a fresh all time high and ETH being on the verge of doing so means we’ve moved from speculative mania to a phase where institutional adoption, real-world integration, and global liquidity are driving price discovery,” said Ben Kurland, CEO at crypto research and trading platform DYOR.
“The fact that both assets are on the verge of breaking records in tandem signals broad market conviction, not just a single-asset rally,” he added. “Momentum this strong rarely burns out instantly, but it also tends to draw in latecomers who can fuel volatility. Right now the story is less about euphoria and more about validation. Crypto is graduating from ‘alternative’ to ‘essential’ in the global portfolio mix.”
Don’t miss these cryptocurrency insights from CNBC Pro: